These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35525099)

  • 1. Neurological phenomenology of the IRF2BPL mutation syndrome: Analysis of a new case and systematic review of the literature.
    Pisano S; Melis M; Figorilli M; Polizzi L; Rocchi L; Giglio S; Defazio G; Muroni A
    Seizure; 2022 Jul; 99():12-15. PubMed ID: 35525099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF2BPL gene variants with dystonia: one new Chinese case report.
    Yang F; Li H; Dai Y; Zhang R; Zhang JT
    BMC Neurol; 2023 Jan; 23(1):32. PubMed ID: 36670390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of IRF2BPL in a Taiwanese dystonia cohort: The genotype and phenotype correlation.
    Chen PS; Chen YF; Chiu JY; Wu MC; Tai CH; Chang YY; Lan MY; Lee NC; Lin CH
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1557-1566. PubMed ID: 38650104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult onset familiar dystonia-plus syndrome: A novel presentation of IRF2BPL-associated neurodegeneration.
    Antonelli F; Grieco G; Cavallieri F; Casella A; Valente EM
    Parkinsonism Relat Disord; 2022 Jan; 94():22-24. PubMed ID: 34864472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF2BPL gene mutation: Expanding on neurologic phenotypes.
    Shelkowitz E; Singh JK; Larson A; Elias ER
    Am J Med Genet A; 2019 Nov; 179(11):2263-2271. PubMed ID: 31432588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy.
    Tran Mau-Them F; Guibaud L; Duplomb L; Keren B; Lindstrom K; Marey I; Mochel F; van den Boogaard MJ; Oegema R; Nava C; Masurel A; Jouan T; Jansen FE; Au M; Chen AH; Cho M; Duffourd Y; Lozier E; Konovalov F; Sharkov A; Korostelev S; Urteaga B; Dickson P; Vera M; Martínez-Agosto JA; Begemann A; Zweier M; Schmitt-Mechelke T; Rauch A; Philippe C; van Gassen K; Nelson S; Graham JM; Friedman J; Faivre L; Lin HJ; Thauvin-Robinet C; Vitobello A
    Genet Med; 2019 Apr; 21(4):1008-1014. PubMed ID: 30166628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo variants of IRF2BPL result in developmental epileptic disorder.
    Wang Y; Ke Z; Li Y; Qiu M; Liu J; Yang Z; Wen S; Liang M; Chen S
    Orphanet J Rare Dis; 2024 Mar; 19(1):121. PubMed ID: 38481258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.
    Gardella E; Michelucci R; Christensen HM; Fenger CD; Reale C; Riguzzi P; Pasini E; Albini-Riccioli L; Papa V; Foschini MP; Cenacchi G; Furia F; Marjanovic D; Hammer TB; Møller RS; Rubboli G
    Epilepsia; 2023 Aug; 64(8):e170-e176. PubMed ID: 37114479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel IRF2BPL gene mutation manifesting as a broad spectrum of neurological disorders: a case report.
    Khan WJ; Maqsood H; Younus S
    BMJ Neurol Open; 2023; 5(2):e000459. PubMed ID: 37649702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel IRF2BPL truncating variant is associated with endolysosomal storage.
    Ginevrino M; Battini R; Nuovo S; Simonati A; Micalizzi A; Contaldo I; Serpieri V; Valente EM
    Mol Biol Rep; 2020 Jan; 47(1):711-714. PubMed ID: 31583567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL.
    Qian XH; Liu XY; Zhu ZY; Wang SG; Song XX; Chen G; Wu JY; Tang HD; Cao L
    Seizure; 2021 Jan; 84():47-52. PubMed ID: 33278788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of epilepsy in children with IRF2BPL gene variation].
    Niu Q; Yang Y; Niu XY; Chen Y; Liu WW; Zhang YH
    Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):506-510. PubMed ID: 34102826
    [No Abstract]   [Full Text] [Related]  

  • 13. IRF2BPL mutations cause autosomal dominant dystonia with anarthria, slow saccades and seizures.
    Ganos C; Zittel S; Hidding U; Funke C; Biskup S; Bhatia KP
    Parkinsonism Relat Disord; 2019 Nov; 68():57-59. PubMed ID: 31621620
    [No Abstract]   [Full Text] [Related]  

  • 14.
    Heide S; Davoine CS; Cunha P; Scherer-Gagou C; Keren B; Stevanin G; Charles P; Heron D; Brice A; Durr A
    Neurol Genet; 2023 Dec; 9(6):e200096. PubMed ID: 38235039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF2BPL Is Associated with Neurological Phenotypes.
    Marcogliese PC; Shashi V; Spillmann RC; Stong N; Rosenfeld JA; Koenig MK; Martínez-Agosto JA; Herzog M; Chen AH; Dickson PI; Lin HJ; Vera MU; Salamon N; Graham JM; Ortiz D; Infante E; Steyaert W; Dermaut B; Poppe B; Chung HL; Zuo Z; Lee PT; Kanca O; Xia F; Yang Y; Smith EC; Jasien J; Kansagra S; Spiridigliozzi G; El-Dairi M; Lark R; Riley K; Koeberl DD; Golden-Grant K; ; ; Yamamoto S; Wangler MF; Mirzaa G; Hemelsoet D; Lee B; Nelson SF; Goldstein DB; Bellen HJ; Pena LDM
    Am J Hum Genet; 2018 Aug; 103(2):245-260. PubMed ID: 30057031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Dystonias: Update on Classification and New Genetic Discoveries.
    Keller Sarmiento IJ; Mencacci NE
    Curr Neurol Neurosci Rep; 2021 Feb; 21(3):8. PubMed ID: 33564903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, Alternating Hemiplegia of Childhood, Rapid-onset Dystonia-Parkinsonism, CAPOS and beyond.
    Sweney MT; Newcomb TM; Swoboda KJ
    Pediatr Neurol; 2015 Jan; 52(1):56-64. PubMed ID: 25447930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental disorder associated with IRF2BPL gene mutation: Expanding the phenotype?
    Skorvanek M; Dusek P; Rydzanicz M; Walczak A; Kosinska J; Kostrzewa G; Brzozowska M; Han V; Dosekova P; Gdovinova Z; Lehotska Z; Lisowski P; Ploski R
    Parkinsonism Relat Disord; 2019 May; 62():239-241. PubMed ID: 30733140
    [No Abstract]   [Full Text] [Related]  

  • 19. IRF2BPL mutation causes nigrostriatal degeneration presenting with dystonia, spasticity and keratoconus.
    Prilop L; Buchert R; Woerz S; Gerloff C; Haack TB; Zittel S
    Parkinsonism Relat Disord; 2020 Oct; 79():141-143. PubMed ID: 32291157
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurological Phenotypes of
    Horovitz DDG; de Faria Domingues de Lima MA; Pires LC; Campos Araujo AQ; Vargas FR
    J Cent Nerv Syst Dis; 2023; 15():11795735231181467. PubMed ID: 37346291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.